FASSI, ENRICO MARIO ALESSANDRO
 Distribuzione geografica
Continente #
AS - Asia 3.083
NA - Nord America 2.720
EU - Europa 2.385
SA - Sud America 296
Continente sconosciuto - Info sul continente non disponibili 262
AF - Africa 82
OC - Oceania 20
Totale 8.848
Nazione #
US - Stati Uniti d'America 2.580
IT - Italia 1.027
CN - Cina 938
SG - Singapore 730
DE - Germania 356
HK - Hong Kong 302
BD - Bangladesh 252
BR - Brasile 220
VN - Vietnam 215
IN - India 191
RU - Federazione Russa 160
GB - Regno Unito 141
JP - Giappone 127
NL - Olanda 113
FR - Francia 106
KR - Corea 104
SE - Svezia 100
CA - Canada 78
CH - Svizzera 63
FI - Finlandia 56
ID - Indonesia 50
TR - Turchia 46
IE - Irlanda 44
PL - Polonia 38
MX - Messico 37
CI - Costa d'Avorio 33
AT - Austria 31
ES - Italia 30
AR - Argentina 28
IR - Iran 18
PK - Pakistan 18
CL - Cile 17
DK - Danimarca 16
LV - Lettonia 16
BE - Belgio 15
BY - Bielorussia 14
ZA - Sudafrica 14
AU - Australia 13
IQ - Iraq 13
EC - Ecuador 11
TH - Thailandia 9
GR - Grecia 8
MY - Malesia 8
TW - Taiwan 8
UA - Ucraina 8
AE - Emirati Arabi Uniti 7
CO - Colombia 7
NZ - Nuova Zelanda 7
PH - Filippine 7
DZ - Algeria 6
EG - Egitto 6
NG - Nigeria 6
RO - Romania 6
VE - Venezuela 6
CR - Costa Rica 5
JO - Giordania 5
LU - Lussemburgo 5
SI - Slovenia 5
AZ - Azerbaigian 4
CZ - Repubblica Ceca 4
LT - Lituania 4
PE - Perù 4
RS - Serbia 4
UZ - Uzbekistan 4
YE - Yemen 4
GE - Georgia 3
HU - Ungheria 3
JM - Giamaica 3
MA - Marocco 3
NI - Nicaragua 3
PT - Portogallo 3
SA - Arabia Saudita 3
AL - Albania 2
BG - Bulgaria 2
BO - Bolivia 2
BS - Bahamas 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
GT - Guatemala 2
IL - Israele 2
KE - Kenya 2
KH - Cambogia 2
MO - Macao, regione amministrativa speciale della Cina 2
NP - Nepal 2
OM - Oman 2
SC - Seychelles 2
SN - Senegal 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
AG - Antigua e Barbuda 1
BH - Bahrain 1
BZ - Belize 1
CW - ???statistics.table.value.countryCode.CW??? 1
EE - Estonia 1
GA - Gabon 1
GM - Gambi 1
KG - Kirghizistan 1
KN - Saint Kitts e Nevis 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
Totale 8.574
Città #
Ashburn 403
Milan 385
Singapore 383
Dallas 335
Hong Kong 233
Hanover 174
San Jose 171
Hefei 158
Santa Clara 142
Los Angeles 126
Beijing 122
Council Bluffs 96
Chandler 83
Ho Chi Minh City 73
New York 70
Hanoi 57
Bengaluru 54
Frankfurt am Main 53
Guangzhou 43
Seoul 43
Southend 42
Boardman 41
Jakarta 41
Dublin 40
Rome 39
Chicago 36
Lauterbourg 36
Moscow 36
Buffalo 34
Shanghai 34
Abidjan 33
Fairfield 32
Tokyo 32
Houston 31
Helsinki 30
Munich 29
Naples 27
Lugano 26
Warsaw 23
Woodbridge 22
Columbus 21
Istanbul 21
Turin 21
Cangzhou 20
Princeton 20
Piscataway 18
São Paulo 18
Wilmington 18
Amsterdam 17
Florence 17
Nuremberg 17
Phoenix 17
Seattle 17
The Dalles 17
Hangzhou 16
London 16
Montreal 16
Riga 16
Brooklyn 15
Cambridge 15
Central 15
Changsha 15
Chengdu 15
Düsseldorf 15
Mexico City 15
Atlanta 14
Berlin 14
Cheongju-si 14
Minsk 14
Lappeenranta 13
Shenzhen 13
Burnaby 12
Cagliari 12
Turku 12
Wuhan 12
Mumbai 11
Orem 11
Poplar 11
San Francisco 11
Tesserete 11
Tradate 11
Varedo 11
Vienna 11
Dong Ket 10
Gongju 10
Hyderabad 10
Pittsburgh 10
Redwood City 10
Rho 10
Rio de Janeiro 10
Santiago 10
Cary 9
Da Nang 9
Denver 9
Fuzhou 9
Modena 9
Monza 9
Nanjing 9
Philadelphia 9
San Diego 9
Totale 4.675
Nome #
Systematic Development of Peptide Inhibitors Targeting the CXCL12/HMGB1 Interaction 539
PCSK9 inhibitors: a patent review 2018-2023 409
Elucidating the 3D Structure of a Surface Membrane Antigen from Trypanosoma cruzi as a Serodiagnostic Biomarker of Chagas Disease 354
Exploring Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Autoproteolysis Process by Molecular Simulations: Hints for Drug Design 342
Structure, Immunoreactivity, and In Silico Epitope Determination of {SmSPI} S. mansoni Serpin for Immunodiagnostic Application 292
Analysis of Hsp90 allosteric modulators interactome reveals a potential dual action mode involving mitochondrial MDH2 278
Natural compounds targeting E. Coli WRBA as antibiofilm agents: Virtual screening, design and synthesis of analogs, biological evaluation 272
Elagolix analogues as potential new GnRH antagonists: design, synthesis and characterization 271
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS 254
Investigation of Chlorella pyrenoidosa Protein as a Source of Novel Angiotensin I-Converting Enzyme (ACE) and Dipeptidyl Peptidase-IV (DPP-IV) Inhibitory Peptides 246
Oxidation State Dependent Conformational Changes of HMGB1 Regulate the Formation of the CXCL12/HMGB1 Heterocomplex 234
γ-hidroxy-lactone derivatives as ppar-γ non-agonists blocking cdk5-mediated phosporylation for a safer anti-diabetic treatment 225
Trans-Epithelial Transport, Metabolism and Biological Activity Assessment of the Multi-Target Lupin Peptide LILPKHSDAD (P5) and Its Metabolite LPKHSDAD (P5-Met) 221
Computational Design, Synthesis, and Biological Evaluation of Diimidazole Analogues Endowed with Dual PCSK9/HMG-CoAR-Inhibiting Activity 220
Elagolix Sodium Salt and Its Synthetic Intermediates: A Spectroscopic, Crystallographic, and Conformational Study 219
Towards a safe treatment of Insulin Resistance: γ-hydroxy lactone-based derivatives as PPARγ non-agonists 216
Natural and nature-inspired compounds targeting E. coli WrbA as antibiofilm agents: computational studies, synthesis, and biological evaluation 213
Computational Design and Biological Evaluation of Analogs of Lupin Peptide P5 Endowed with Dual PCSK9/HMG-CoAR Inhibiting Activity 213
COMPUTATIONAL DESIGN OF PEPTIDES AND PEPTIDOMIMETICS AS POTENTIAL THERAPEUTIC AGENTS TO SATISFY PRESSING MEDICAL NEEDS 204
Insights on the atropisomeric properties of elagolix and its derivatives 204
Elagolix analogues as potential new GnRH antagonists 200
Unlocking the Antibiofilm Potential of Natural Compounds by Targeting the NADH:quinone Oxidoreductase WrbA 195
Novel Non-peptide Uracil-derived Human Gonadotropin-Releasing Hormone Receptor Antagonists 191
Enhancing the activity of γ-hydroxy lactone derivatives as innovative peroxisome proliferator-activated receptor γ non-agonists inhibiting cyclin-dependent kinase 5-mediated phosphorylation 188
Mechanistic Insights into the Antibiofilm Mode of Action of Ellagic Acid 184
Computational Design, Synthesis, and Biophysical Evaluation of β-Amido Boronic Acids as SARS-CoV-2 Mpro Inhibitors 180
FYCO1 Peptide Analogs: Design and Characterization of Autophagy Inhibitors as Co-Adjuvants in Taxane Chemotherapy of Prostate Cancer 176
Modulatori Fotosensibili dell’adesione batterica: una nuova strategia per ridurre l’antibiotico-resistenza 170
A potent nonapeptide inhibitor for the CXCL12/HMGB1 heterocomplex: A computational and experimental approach 170
A new class of GnRH receptor modulators endowed with atropisomerism 166
Light-Responsive Modulators of Bacterial Cell Adhesion Proteins: a Novel Strategy against AMR? 160
Nature‐Inspired Compounds Targeting Escherichia coli WrbA as Biofilm‐Modulating Agents: Computational Design, Synthesis, and Biological Evaluation 159
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines 159
High‐throughput peptide array analysis and computational techniques for serological profiling of flavivirus infections: Implications for diagnostics and vaccine development 159
γ-HYDROXY LACTONE BASED PPARγ NON-AGONISTS AS SAFE AND INNOVATIVE ANTI-DIABETIC AGENTS. 149
Insights on Zosteric Acid Analogues Activity Against Candida albicans Biofilm Formation 135
Focused Design of Novel Cyclic Peptides Endowed with GABARAP-Inhibiting Activity 132
Development of AMBER Parameters for Molecular Simulations of Selected Boron-Based Covalent Ligands 109
Spatiotemporal Control of Bacterial Adhesion via Light-Responsive Modulators 83
Insights into the catalytic mechanism of formate dehydrogenases from different microbial sources 55
Design and synthesis of CD70 inhibitors: a potential way for the treatment of ulcerative colitis 53
Support Vector Machine Identification of Small Molecule Binders to an Understudied Allosteric Site of SARS‐CoV‐2 Mpro for Next‐Generation PROTAC‐Based Therapeutics 46
Design, synthesis and characterization of novel potential TAU-degraders 35
Synthesis of Self-Assembling Proteolysis Targeting Chimeras Based on Biorthogonal Reactions 31
Endoplasmic Reticulum and Lysosomal Quality Control of Four Nonsense Mutants of Iduronate 2-Sulfatase Linked to Hunter{'}s Syndrome 29
PCSK9 inhibitors: an updated patent review 2024–2025 28
Computational Analysis of Dengue Virus Envelope Protein (E) Reveals an Epitope with Flavivirus Immunodiagnostic Potential in Peptide Microarrays 21
Targeting Pseudomonas aeruginosa LecB with Photoswitchable Glycomimetic Ligands 20
Breakable Organosilica Nanocapsules for the Intracellular Delivery of a Peptide With Promising Anti‐Breast Cancer Activity 15
Development of In-Cell Self-Assembly Proteolysis Targeting Chimeras Exploiting the Biorthogonal Reaction Between Vinyl Boronic Acids and 1,2,4,5-Tetrazines 10
null 9
Protein language model-generated enzyme sequences exhibit high stability in molecular dynamics simulations 3
Finenzyme-generated enzymes with predicted structures (ESMfold) 2
Totale 8.848
Categoria #
all - tutte 25.619
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.619


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022514 0 0 16 16 40 25 33 43 119 92 74 56
2022/2023483 43 55 37 33 25 50 5 63 48 23 50 51
2023/2024851 42 32 59 74 123 62 135 43 44 57 94 86
2024/20251.582 67 121 43 132 101 91 97 160 77 147 238 308
2025/20264.569 384 393 583 488 364 205 540 172 379 316 400 345
2026/2027563 237 322 4 0 0 0 0 0 0 0 0 0
Totale 8.848